Right ventricular ejection fraction measured by multigated planar equilibrium radionuclide ventriculography is an independent prognostic factor in patients with ischemic heart disease

Journal of Nuclear Cardiology

Volumn 19, Issue 6, 2012, Pages 1162-1169

  Van Der Maas, N ^a,b   Braam, R L ^a   Van Der Zaag Loonen, H J ^a   Meerman, J ^a   Cozijnsen, L ^a   Scholte, A J H A ^b  

^a GELRE HOSPITALS   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ischemic heart disease; multigated planar equilibrium radionuclide ventriculography; prognosis; Right ventricular ejection fraction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PERTECHNETIC ACID TC 99M;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIGATED PLANAR EQUILIBRIUM RADIONUCLIDE VENTRICULOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOISOTOPE VENTRICULOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; ALGORITHM; ANALYSIS OF VARIANCE; CARDIAC GATED IMAGING; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANALYSIS OF VARIANCE; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, RIGHT;

EID: 84879189882     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9613-y     Document Type: Article

References (26)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-90.
2. Ahmed A, Perry GJ, Fleg JL, Love TE, Goff DC Jr, Kitzman DW. Outcomes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis. Am Heart J 2006;152:956-66.
3. Martinez-Selles M, Garcia Robles JA, Prieto L, Dominguez MM, Frades E, Diaz-Castro O, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 2003;24:2046-53.
4. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, et al. Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
5. Meyer P, Filippatos GS, Ahmed MI, Iskandrian AE, Bittner V, Perry GJ, et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010;121:252-8.
6. Antoni ML, Scherptong RW, Atary JZ, Boersma E, Holman ER, van der Wall EE, et al. Prognostic value of right ventricular function in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Circ Cardiovasc Imaging 2010;3:264-71.
7. Zornoff LA, Skali H, Pfeffer MA, St John SM, Rouleau JL, Lamas GA, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 2002;39:1450-5.
8. Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, et al. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol 2008;101:607-12.
9. Nesser HJ, Tkalec W, Patel AR, Masani ND, Niel J, Markt B, et al. Quantitation of right ventricular volumes and ejection fraction by three-dimensional echocardiography in patients: Comparison with magnetic resonance imaging and radionuclide ventriculography. Echocardiography 2006;23:666-80.
10. Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006;47:605-10.
11. Ducassou D, Arnaud D, Bardy A, Beydon J, Baquey C. A new stannous agent kit for labelling red blood cells with 99TCM and its clinical application. Br J Radiol 1976;49:344-7.
12. Manno BV, Iskandrian AS, Hakki AH. Right ventricular function: methodologic and clinical considerations in noninvasive scintigraphic assessment. J Am Coll Cardiol 1984;3:1072-81.
13. Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging 2008;35:851-85.
14. Maeder MT, Kaye DM. Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2009;53:905-18.
15. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
16. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436-48.
17. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-31.
18. Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol 2001;37:37-43.
19. Popescu BA, Antonini-Canterin F, Temporelli PL, Giannuzzi P, Bosimini E, Gentile F, et al. Right ventricular functional recovery after acute myocardial infarction: relation with left ventricular function and interventricular septum motion. GISSI-3 echo substudy. Heart 2005;91:484-8.
20. Kaul S, Hopkins JM, Shah PM. Chronic effects of myocardial infarction on right ventricular function: A noninvasive assessment. J Am Coll Cardiol 1983;2:607-15.
21. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983;2:217-24.
22. Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007;49:855-62.
23. Sakata K, Yoshino H, Kurihara H, Iwamori K, Houshaku H, Yanagisawa A, et al. Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction. Am J Cardiol 2000;85:939-44.
24. Shah PK, Maddahi J, Berman DS, Pichler M, Swan HJ. Scintigraphically detected predominant right ventricular dysfunction in acute myocardial infarction: Clinical and hemodynamic correlates and implications for therapy and prognosis. J Am Coll Cardiol 1985;6:1264-72.
25. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, et al. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951-60.
26. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007;116:1555-62.